Publication | Open Access

Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection

Surgical OncologyMalignant Pleural MesotheliomaMedicinePleural DiseaseSurgeryMetronomic ChemotherapyCancer TreatmentOncologyRadiation OncologyLow-risk Patients